Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity

Background: Streptokinase (SK) is a potent plasminogen activator naturally produced by beta-hemolytic streptococcus bacteria and used as a thrombolytic drug. Objectives: Optimize high yield production of recombinant streptokinase (rSK) in Escherichia coli and evaluate its thrombolytic activity. Meth...

Full description

Bibliographic Details
Main Authors: Ehab El-Dabaa, Hend Okasha, Safia Samir, Sami Mohamed Nasr, Hadeer Adel El-Kalamawy, Mohamed Ali Saber
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Arabian Journal of Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878535222001150
_version_ 1811279477455454208
author Ehab El-Dabaa
Hend Okasha
Safia Samir
Sami Mohamed Nasr
Hadeer Adel El-Kalamawy
Mohamed Ali Saber
author_facet Ehab El-Dabaa
Hend Okasha
Safia Samir
Sami Mohamed Nasr
Hadeer Adel El-Kalamawy
Mohamed Ali Saber
author_sort Ehab El-Dabaa
collection DOAJ
description Background: Streptokinase (SK) is a potent plasminogen activator naturally produced by beta-hemolytic streptococcus bacteria and used as a thrombolytic drug. Objectives: Optimize high yield production of recombinant streptokinase (rSK) in Escherichia coli and evaluate its thrombolytic activity. Methods: Synthetic gene encoding mature SK protein with optimization for rare codons and mRNA secondary structure was cloned into the expression vector pET-3a and transformed into Escherichia coli BL21 (DE3). Seed banks were established for high rSK expression clones. The native rSK protein expression was optimized using IPTG induction. The nonsoluble rSK inclusion bodies were purified, denatured in 6 M guanidinium chloride, and refolded using the rapid dilution method. The refolded rSK protein was purified using anion exchange chromatography and evaluated with ELISA. The activity of rSK was evaluated using the casein digestion method and in vitro blood clot lysis assay with reference drug Sedonase as standard. Results: Seed banks with high stable expression of native rSk (MW 47 kDa) were established. High rSK expression was optimized using 1 mM IPTG at bacterial OD600 0.6. The refolded rSK was prepared and purified successfully with high productivity (494 mg purified rsk/L culture). Using ELISA, the purified rSK molecular identity and conservation of native SK epitopes were confirmed. The enzymatic activity of the purified rSK was 1.945x106 IU/mg with 62.94 ± 2.3% clot lysis efficiency. Conclusion: A high yield production of proper rSK protein with in vitro thrombolytic activity similar to commercial SK has been achieved, suggesting a more cost-effective industrial production of its biosimilar drug.
first_indexed 2024-04-13T00:55:18Z
format Article
id doaj.art-6f0152ff86b7418f8afc005c3562b4bf
institution Directory Open Access Journal
issn 1878-5352
language English
last_indexed 2024-04-13T00:55:18Z
publishDate 2022-05-01
publisher Elsevier
record_format Article
series Arabian Journal of Chemistry
spelling doaj.art-6f0152ff86b7418f8afc005c3562b4bf2022-12-22T03:09:42ZengElsevierArabian Journal of Chemistry1878-53522022-05-01155103799Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activityEhab El-Dabaa0Hend Okasha1Safia Samir2Sami Mohamed Nasr3Hadeer Adel El-Kalamawy4Mohamed Ali Saber5Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, EgyptDepartment of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, EgyptDepartment of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, EgyptCorresponding author at: Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, Egypt.; Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, EgyptDepartment of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, EgyptDepartment of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, EgyptBackground: Streptokinase (SK) is a potent plasminogen activator naturally produced by beta-hemolytic streptococcus bacteria and used as a thrombolytic drug. Objectives: Optimize high yield production of recombinant streptokinase (rSK) in Escherichia coli and evaluate its thrombolytic activity. Methods: Synthetic gene encoding mature SK protein with optimization for rare codons and mRNA secondary structure was cloned into the expression vector pET-3a and transformed into Escherichia coli BL21 (DE3). Seed banks were established for high rSK expression clones. The native rSK protein expression was optimized using IPTG induction. The nonsoluble rSK inclusion bodies were purified, denatured in 6 M guanidinium chloride, and refolded using the rapid dilution method. The refolded rSK protein was purified using anion exchange chromatography and evaluated with ELISA. The activity of rSK was evaluated using the casein digestion method and in vitro blood clot lysis assay with reference drug Sedonase as standard. Results: Seed banks with high stable expression of native rSk (MW 47 kDa) were established. High rSK expression was optimized using 1 mM IPTG at bacterial OD600 0.6. The refolded rSK was prepared and purified successfully with high productivity (494 mg purified rsk/L culture). Using ELISA, the purified rSK molecular identity and conservation of native SK epitopes were confirmed. The enzymatic activity of the purified rSK was 1.945x106 IU/mg with 62.94 ± 2.3% clot lysis efficiency. Conclusion: A high yield production of proper rSK protein with in vitro thrombolytic activity similar to commercial SK has been achieved, suggesting a more cost-effective industrial production of its biosimilar drug.http://www.sciencedirect.com/science/article/pii/S1878535222001150StreptokinaseExpressionRefoldingPurificationActivity assays
spellingShingle Ehab El-Dabaa
Hend Okasha
Safia Samir
Sami Mohamed Nasr
Hadeer Adel El-Kalamawy
Mohamed Ali Saber
Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
Arabian Journal of Chemistry
Streptokinase
Expression
Refolding
Purification
Activity assays
title Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
title_full Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
title_fullStr Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
title_full_unstemmed Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
title_short Optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
title_sort optimization of high expression and purification of recombinant streptokinase and in vitro evaluation of its thrombolytic activity
topic Streptokinase
Expression
Refolding
Purification
Activity assays
url http://www.sciencedirect.com/science/article/pii/S1878535222001150
work_keys_str_mv AT ehabeldabaa optimizationofhighexpressionandpurificationofrecombinantstreptokinaseandinvitroevaluationofitsthrombolyticactivity
AT hendokasha optimizationofhighexpressionandpurificationofrecombinantstreptokinaseandinvitroevaluationofitsthrombolyticactivity
AT safiasamir optimizationofhighexpressionandpurificationofrecombinantstreptokinaseandinvitroevaluationofitsthrombolyticactivity
AT samimohamednasr optimizationofhighexpressionandpurificationofrecombinantstreptokinaseandinvitroevaluationofitsthrombolyticactivity
AT hadeeradelelkalamawy optimizationofhighexpressionandpurificationofrecombinantstreptokinaseandinvitroevaluationofitsthrombolyticactivity
AT mohamedalisaber optimizationofhighexpressionandpurificationofrecombinantstreptokinaseandinvitroevaluationofitsthrombolyticactivity